CpG Demethylation Enhances Alpha-Synuclein Expression and Affects the Pathogenesis of Parkinson's Disease

被引:234
作者
Matsumoto, Lumine [1 ]
Takuma, Hiroshi [3 ]
Tamaoka, Akira [3 ]
Kurisaki, Hiroshi [4 ]
Date, Hidetoshi [1 ]
Tsuji, Shoji [1 ]
Iwata, Atsushi [1 ,2 ,5 ]
机构
[1] Univ Tokyo, Grad Sch Med, Dept Neurol, Div Neurosci,Bunkyo Ku, Tokyo, Japan
[2] Univ Tokyo, Grad Sch Med, Dept Mol Neurosci Neurodegenerat, Bunkyo Ku, Tokyo, Japan
[3] Univ Tsukuba, Dept Neurol, Tsukuba, Ibaraki, Japan
[4] Tokyo Hosp, Natl Hosp Org, Dept Neurol, Tokyo, Japan
[5] Japan Sci & Technol Agcy, PRESTO, Kawaguchi, Saitama, Japan
来源
PLOS ONE | 2010年 / 5卷 / 11期
基金
日本学术振兴会;
关键词
NEUROBLASTOMA SH-SY5Y CELLS; LEWY BODIES; DNA METHYLATION; TRANSCRIPTIONAL REGULATION; MESSENGER-RNA; UP-REGULATION; DEMENTIA; GENE; CANCER; BRAIN;
D O I
10.1371/journal.pone.0015522
中图分类号
O [数理科学和化学]; P [天文学、地球科学]; Q [生物科学]; N [自然科学总论];
学科分类号
07 ; 0710 ; 09 ;
摘要
Background: Alpha-synuclein (SNCA) gene expression is an important factor in the pathogenesis of Parkinson's disease (PD). Gene multiplication can cause inherited PD, and promoter polymorphisms that increase SNCA expression are associated with sporadic PD. CpG methylation in the promoter region may also influence SNCA expression. Methodology/Principal Findings: By using cultured cells, we identified a region of the SNCA CpG island in which the methylation status altered along with increased SNCA expression. Postmortem brain analysis revealed regional non-specific methylation differences in this CpG region in the anterior cingulate and putamen among controls and PD; however, in the substantia nigra of PD, methylation was significantly decreased. Conclusions/Significance: This CpG region may function as an intronic regulatory element for SNCA gene. Our findings suggest that a novel epigenetic regulatory mechanism controlling SNCA expression influences PD pathogenesis.
引用
收藏
页数:9
相关论文
共 40 条
[1]   DNA Methylation of Alzheimer Disease and Tauopathy-Related Genes in Postmortem Brain [J].
Barrachina, Marta ;
Ferrer, Isidre .
JOURNAL OF NEUROPATHOLOGY AND EXPERIMENTAL NEUROLOGY, 2009, 68 (08) :880-891
[2]   Differential expression of α-synuclein isoforms in dementia with Lewy bodies [J].
Beyer, K ;
Lao, JI ;
Carrato, C ;
Mate, JL ;
López, D ;
Ferrer, I ;
Ariza, A .
NEUROPATHOLOGY AND APPLIED NEUROBIOLOGY, 2004, 30 (06) :601-607
[3]   Demonstration of Amyloid Deposits and Neurofibrillary Changes in Whole Brain Sections [J].
Braak, Heiko ;
Braak, Eva .
BRAIN PATHOLOGY, 1991, 1 (03) :213-216
[4]   α-synuclein locus duplication as a cause of familial Parkinson's disease [J].
Chartier-Harlin, MC ;
Kachergus, J ;
Roumier, C ;
Mouroux, V ;
Douay, X ;
Lincoln, S ;
Levecque, C ;
Larvor, L ;
Andrieux, J ;
Hulihan, M ;
Waucquier, N ;
Defebvre, L ;
Amouyel, P ;
Farrer, M ;
Destée, A .
LANCET, 2004, 364 (9440) :1167-1169
[5]   Levels of alpha-synuclein mRNA in sporadic Parkinson disease patients [J].
Chiba-Falek, Ornit ;
Lopez, Grisel J. ;
Nussbaum, Robert L. .
MOVEMENT DISORDERS, 2006, 21 (10) :1703-1708
[6]  
CLARK SJ, 1994, NUCLEIC ACIDS RES, V22, P2990, DOI 10.1093/nar/22.15.2990
[7]   A novel pathway for transcriptional regulation of α-synuclein [J].
Clough, R. Lee ;
Stefanis, Leonidas .
FASEB JOURNAL, 2007, 21 (02) :596-607
[8]   Functional dissection of the α-synuclein promoter: transcriptional regulation by ZSCAN21 and ZNF219 [J].
Clough, Richard Lee ;
Dermentzaki, Georgia ;
Stefanis, Leonidas .
JOURNAL OF NEUROCHEMISTRY, 2009, 110 (05) :1479-1490
[9]   The ups and downs of α-synuclein mRNA expression [J].
Daechsel, Justus C. ;
Lincoln, Sarah J. ;
Gonzalez, John ;
Ross, Owen A. ;
Dickson, Dennis W. ;
Farrer, Matthew J. .
MOVEMENT DISORDERS, 2007, 22 (02) :293-295
[10]   Epidemiology of Parkinson's disease [J].
de Lau, Lonneke M. L. ;
Breteler, Monique M. B. .
LANCET NEUROLOGY, 2006, 5 (06) :525-535